Involvement of visfatin in palmitate-induced upregulation of inflammatory cytokines in hepatocytes

Metabolism: Clinical and Experimental

Volumn 60, Issue 12, 2011, Pages 1781-1789

  Choi, Yong Jun ^a   Choi, Sung E ^a   Ha, Eun Suk ^a   Kang, Yup ^a   Han, Seung Jin ^a   Kim, Dae Jung ^a   Lee, Kwan Woo ^a   Kim, Hae Jin ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B ALPHA; INTERLEUKIN 6; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; SMALL INTERFERING RNA; SN 50; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INSULIN RESISTANCE; LIVER CELL; LIVER LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT;

ADENOVIRIDAE INFECTIONS; ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEP G2 CELLS; HEPATOCYTES; HUMANS; I-KAPPA B PROTEINS; IMMUNOBLOTTING; INFLAMMATION; INSULIN RESISTANCE; INTERLEUKIN-6; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY; PALMITIC ACID; PEPTIDES; RATS; RATS, ZUCKER; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 81155131770     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2011.05.003     Document Type: Article

References (28)

1. A.N. Mokdad, B.A. Bowman, and E.S. Ford The continuing epidemic of obesity and diabetes in the United States JAMA 286 2001 1195 1200 (Pubitemid 33015548)
2. G. Boden Free fatty acids as targets for therapy Curr Opin Endocrinol Diabetes 11 2004 258 263 (Pubitemid 44616207)
3. E. Maury, and S.M. Brichard Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome Mol Cell Endocrinol 314 2010 1 16
4. G. Boden, P. She, and M. Mozzoli Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-κB pathway in rat liver Diabetes 54 2005 3458 3465 (Pubitemid 43334336)
5. A. Fukuhara, M. Matsuda, and M. Nishizawa Visfatin: a protein secreted by visceral fat that mimics the effects of insulin Science 307 2005 426 430 Retracted (Pubitemid 40139988)
6. R. Aller, D.A. de Luis, and O. Izaola Influence of visfatin on histopathological changes of non-alcoholic fatty liver disease Dig Dis Sci 54 2009 1772 1777
7. A. Garten, S. Petzold, and A. Barnikol-Oettler Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes Biochem Biophys Res Commun 391 2010 376 381
8. J.R. Revollo, A. Korner, and K.F. Mills Nampt/PBEF/visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme Cell Metab 6 2007 363 375 (Pubitemid 350011996)
9. S.H. Jia, Y. Li, and J. Parodo Pre-B-cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis J Clin Invest 113 2004 1318 1327 (Pubitemid 39069931)
10. F. Brentano, O. Schorr, and C. Ospelt Pre-B-cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities Arthritis Rheum 56 2007 2829 2839 (Pubitemid 47502729)
11. J.G. Garcia, and L. Moreno Vinasco Genomic insights into acute inflammatory lung injury Am J Physiol Lung Cell Mol Physiol 291 2006 L1113 L1117
12. M. Zhong, H.W. Tan, and H. Gong Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis Clin Endocrinol(Oxf) 69 2008 878 884
13. R. Retnakaran, B.S. Youn, and Y. Liu Correlation of circulating full-length visfatin (PBEF/NAMPT) with metabolic parameters in subjects with and without diabetes: a cross-sectional study Clin Endocrinol (Oxf) 69 2008 885 893
14. J.M. Haus, T.P. Solomon, and C.M. Marchetti Decreased visfatin after exercise training correlates with improved glucose tolerance Med Sci Sports Exerc 41 2009 1255 1260
15. L.L. Listenberger, D.S. Ory, and J.E. Schaffer Palmitate-induced apoptosis can occur through a ceramide-independent pathway J Bio Chem 276 2001 14890 14895
16. E. Shafrir, and E. Ziv A useful list of spontaneously arising animal models of obesity and diabetes Am J Physiol Endocrinol Metab 296 2009 E1450 E1452
17. E. Shafrir Animal models of non-insulin dependent diabetes Diabetes Metab Rev 8 1992 179 208 (Pubitemid 23053235)
18. A.R. Moschen, A. Kaser, and B. Enrich Visfatin, an adipocytokine with proinflammatory and immunomodulating properties J Immunol 178 2007 1748 1758 (Pubitemid 46154646)
19. H. Tilg, and A.R. Moschen Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases Clin Sci (Lond) 114 2008 275 288 (Pubitemid 351294003)
20. Y. Li, Y. Zhang, and B. Dorweiler Extracellular Nampt promotes macrophage survival via a non-enzymatic interleukin-6/STAT 3 signaling mechanism J Biol Chem 283 2008 34833 34843
21. A.R. Moschen, R.R. Gerner, and H. Tilg Pre-B-cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity related disorders Curr Pharm Des 16 2010 1913 1920
22. P.O. Hassa, and M.O. Hottiger The functional role of poly (ADP-ribose) polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders Cell Mol Life Sci 59 2002 1534 1553 (Pubitemid 35239308)
23. F. Van Gool, M. Galli, and C. Gueydan Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner Nat Med 15 2009 206 210
24. R.C. Oita, D. Ferdinando, and S. Wilson Visfatin induces oxidative stress in differentiated C2C12 myotubes in an Akt- and MAPK-independent, NFkB-dependent manner Pflugers Arch 459 2010 619 630
25. S.R. Kim, Y.H. Bae, and S.K. Bae Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells Biochim Biophys Acta 1783 2008 886 895
26. T. Inoguchi, P. Li, and F. Umeda High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells Diabetes 49 2000 1939 1945
27. M. Karin, Y. Yamamoto, and Q.M. Wang The IKK NFκB system: a treasure trove for drug development Nat Rev 3 2004 17 26 (Pubitemid 38088695)
28. P.J. Barnes, and M. Karin Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases N Engl J Med 336 1997 1066 1071 (Pubitemid 27163860)